Liver disease is a major health concern, causing millions of deaths worldwide each year. One serious complication is liver fibrosis, scarring that can lead to liver failure. There is currently no ...

This paper explores the feasibility and principle of hepatic parenteral fluorescence imaging technology after retrograde injection of indocyanine green (ICG) through endoscopic nasobiliary drainage ...

One of the main pathogenic processes of liver fibrosis is thought to be the activation of hepatic stellate cells (HSCs) 1. Located in the area between hepatocytes and sinusoidal endothelial cells, ...

Development and validation of a postoperative nomogram for predicting survival in gallbladder cancer patients: Insights from SEER and external cohorts. This is an ASCO Meeting Abstract from the 2025 ...

Scientists from the Medical Faculty Mannheim, Heidelberg University have developed a model system that can be used to test the efficacy of drugs for fatty liver disease. It is a three-dimensional (3D) ...

The central vein (CV) region, driven by the Wnt signaling pathway, and the portal vein (PV) region, driven by the Notch signaling pathway, enable us to construct a biomimetic liver lobule ...

Impact of diabetes mellitus on the outcome of colon cancer No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2004 ASCO Annual Meeting. This abstract does ...

A liver cancer diagnosis frequently leads to surgery, with the goal of completely removing all malignant tissue. To ensure ...

Liver fibrosis may be diagnosed and staged — no fibrosis (stage F0), mild fibrosis (F1), significant fibrosis (F2), advanced fibrosis (F3), and cirrhosis (F4) — with the use of clinical parameters and ...

In response to chronic stimuli such as alcohol abuse, viral infection, NAFLD/NASH and toxic damage, liver loses its normal structure and non-parenchymal cells including HSCs, KCs and LSECs undergo ...